SMCR7L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.178800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.177600E-01
Normal-vs-Stage2
3.882600E-01
Normal-vs-Stage3
1.060030E-01
Normal-vs-Stage4
8.114400E-01
Stage1-vs-Stage2
1.203980E-01
Stage1-vs-Stage3
2.973700E-02
Stage1-vs-Stage4
5.715800E-01
Stage2-vs-Stage3
2.781000E-01
Stage2-vs-Stage4
5.080000E-01
Stage3-vs-Stage4
1.190960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.084600E-01
Normal-vs-AfricanAmerican
8.325000E-01
Normal-vs-Asian
2.202200E-01
Caucasian-vs-AfricanAmerican
1.326800E-01
Caucasian-vs-Asian
5.731400E-01
AfricanAmerican-vs-Asian
7.190400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.442800E-01
Normal-vs-Female
5.401800E-01
Male-vs-Female
1.761000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.365000E-01
Normal-vs-Age(41-60Yrs)
5.458200E-01
Normal-vs-Age(61-80Yrs)
3.730200E-01
Normal-vs-Age(81-100Yrs)
5.327600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.936600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.841400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.662000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.177600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.696000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.459400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.723600E-02
Normal-vs-Daily Drinker
9.445500E-02
Normal-vs-Weekly Drinker
6.565600E-01
Normal-vs-Occasional Drinker
7.817200E-01
Normal-vs-Social Drinker
4.957000E-01
Non Drinker-vs-Daily Drinker
9.039000E-01
Non Drinker-vs-Weekly Drinker
5.422400E-02
Non Drinker-vs-Occasional Drinker
5.760000E-03
Non Drinker-vs-Social Drinker
5.519800E-02
Daily Drinker-vs-Weekly Drinker
7.572500E-02
Daily Drinker-vs-Occasional Drinker
1.141630E-02
Daily Drinker-vs-Social Drinker
7.390200E-02
Weekly Drinker-vs-Occasional Drinker
6.806600E-01
Weekly Drinker-vs-Social Drinker
8.470000E-01
Occasional Drinker-vs-Social Drinker
4.879000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.537000E-01
Normal-vs-Grade 2
9.536400E-01
Normal-vs-Grade 3
9.697200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.985200E-01
Grade 1-vs-Grade 3
8.208600E-01
Grade 1-vs-Grade 4
9.537000E-01
Grade 2-vs-Grade 3
7.444400E-01
Grade 2-vs-Grade 4
9.536400E-01
Grade 3-vs-Grade 4
9.697200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.419600E-01
Normal-vs-NonDiabetic
3.129600E-01
Diabetic-vs-NonDiabetic
3.845800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.685600E-01
Normal-vs-NoPancreatitis
3.074600E-01
Pancreatitis-vs-NoPancreatitis
9.120600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.598200E-01
Normal-vs-N1
4.204400E-01
N0-vs-N1
9.215200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.407800E-01
Normal-vs-TP53-NonMutant
9.584200E-01
TP53-Mutant-vs-TP53-NonMutant
3.749600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
